FRESHPET INC (FRPT)

US3580391056 - Common Stock

109.58  +2.5 (+2.33%)

After market: 109.8 +0.22 (+0.2%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to FRPT. FRPT was compared to 92 industry peers in the Food Products industry. FRPT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. FRPT is valued quite expensive, but it does show an excellent growth.



2

1. Profitability

1.1 Basic Checks

FRPT had negative earnings in the past year.
FRPT had a positive operating cash flow in the past year.
FRPT had negative earnings in each of the past 5 years.
FRPT had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -2.30%, FRPT is in line with its industry, outperforming 40.66% of the companies in the same industry.
With a Return On Equity value of -3.54%, FRPT perfoms like the industry average, outperforming 43.96% of the companies in the same industry.
Industry RankSector Rank
ROA -2.3%
ROE -3.54%
ROIC N/A
ROA(3y)-3.79%
ROA(5y)-2.54%
ROE(3y)-4.47%
ROE(5y)-3.06%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 32.72%, FRPT belongs to the top of the industry, outperforming 81.32% of the companies in the same industry.
In the last couple of years the Gross Margin of FRPT has declined.
The Profit Margin and Operating Margin are not available for FRPT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 32.72%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.86%
GM growth 5Y-6.83%

5

2. Health

2.1 Basic Checks

FRPT does not have a ROIC to compare to the WACC, probably because it is not profitable.
FRPT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, FRPT has more shares outstanding
FRPT has a worse debt/assets ratio than last year.

2.2 Solvency

FRPT has an Altman-Z score of 6.50. This indicates that FRPT is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 6.50, FRPT belongs to the best of the industry, outperforming 89.01% of the companies in the same industry.
FRPT has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
FRPT has a Debt to Equity ratio (0.44) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF N/A
Altman-Z 6.5
ROIC/WACCN/A
WACC9%

2.3 Liquidity

A Current Ratio of 4.79 indicates that FRPT has no problem at all paying its short term obligations.
The Current ratio of FRPT (4.79) is better than 92.31% of its industry peers.
A Quick Ratio of 4.08 indicates that FRPT has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 4.08, FRPT belongs to the best of the industry, outperforming 95.60% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.79
Quick Ratio 4.08

7

3. Growth

3.1 Past

FRPT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.38%, which is quite impressive.
The Revenue has grown by 28.81% in the past year. This is a very strong growth!
The Revenue has been growing by 31.75% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)45.38%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q616.67%
Revenue 1Y (TTM)28.81%
Revenue growth 3Y33.99%
Revenue growth 5Y31.75%
Revenue growth Q2Q29.93%

3.2 Future

FRPT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 49.57% yearly.
FRPT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 24.78% yearly.
EPS Next Y105.33%
EPS Next 2Y71.2%
EPS Next 3Y49.57%
EPS Next 5YN/A
Revenue Next Year26.29%
Revenue Next 2Y25.28%
Revenue Next 3Y24.59%
Revenue Next 5Y24.78%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

FRPT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 2897.29, FRPT can be considered very expensive at the moment.
FRPT's Price/Forward Earnings is on the same level as the industry average.
FRPT is valuated expensively when we compare the Price/Forward Earnings ratio to 20.88, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 2897.29

4.2 Price Multiples

61.54% of the companies in the same industry are cheaper than FRPT, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 169.69

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as FRPT's earnings are expected to grow with 49.57% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y71.2%
EPS Next 3Y49.57%

0

5. Dividend

5.1 Amount

FRPT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

FRESHPET INC

NASDAQ:FRPT (5/3/2024, 7:00:00 PM)

After market: 109.8 +0.22 (+0.2%)

109.58

+2.5 (+2.33%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap5.29B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2897.29
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.3%
ROE -3.54%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 32.72%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.79
Quick Ratio 4.08
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)45.38%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y105.33%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)28.81%
Revenue growth 3Y33.99%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y